Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12882930rdf:typepubmed:Citationlld:pubmed
pubmed-article:12882930lifeskim:mentionsumls-concept:C0011881lld:lifeskim
pubmed-article:12882930lifeskim:mentionsumls-concept:C0039840lld:lifeskim
pubmed-article:12882930lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:12882930lifeskim:mentionsumls-concept:C0053116lld:lifeskim
pubmed-article:12882930pubmed:issue8lld:pubmed
pubmed-article:12882930pubmed:dateCreated2003-7-28lld:pubmed
pubmed-article:12882930pubmed:abstractTextAccumulation of triosephosphates arising from high cytosolic glucose concentrations in hyperglycemia is the trigger for biochemical dysfunction leading to the development of diabetic nephropathy-a common complication of diabetes associated with a high risk of cardiovascular disease and mortality. Here we report that stimulation of the reductive pentosephosphate pathway by high-dose therapy with thiamine and the thiamine monophosphate derivative benfotiamine countered the accumulation of triosephosphates in experimental diabetes and inhibited the development of incipient nephropathy. High-dose thiamine and benfotiamine therapy increased transketolase expression in renal glomeruli, increased the conversion of triosephosphates to ribose-5-phosphate, and strongly inhibited the development of microalbuminuria. This was associated with decreased activation of protein kinase C and decreased protein glycation and oxidative stress-three major pathways of biochemical dysfunction in hyperglycemia. Benfotiamine also inhibited diabetes-induced hyperfiltration. This was achieved without change in elevated plasma glucose concentration and glycated hemoglobin in the diabetic state. High-dose thiamine and benfotiamine therapy is a potential novel strategy for the prevention of clinical diabetic nephropathy.lld:pubmed
pubmed-article:12882930pubmed:languageenglld:pubmed
pubmed-article:12882930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882930pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12882930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12882930pubmed:statusMEDLINElld:pubmed
pubmed-article:12882930pubmed:monthAuglld:pubmed
pubmed-article:12882930pubmed:issn0012-1797lld:pubmed
pubmed-article:12882930pubmed:authorpubmed-author:ThornalleyPau...lld:pubmed
pubmed-article:12882930pubmed:authorpubmed-author:AhmedNailaNlld:pubmed
pubmed-article:12882930pubmed:authorpubmed-author:BattahSinanSlld:pubmed
pubmed-article:12882930pubmed:authorpubmed-author:Babaei-Jadidi...lld:pubmed
pubmed-article:12882930pubmed:authorpubmed-author:KarachaliasNi...lld:pubmed
pubmed-article:12882930pubmed:issnTypePrintlld:pubmed
pubmed-article:12882930pubmed:volume52lld:pubmed
pubmed-article:12882930pubmed:ownerNLMlld:pubmed
pubmed-article:12882930pubmed:authorsCompleteYlld:pubmed
pubmed-article:12882930pubmed:pagination2110-20lld:pubmed
pubmed-article:12882930pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:meshHeadingpubmed-meshheading:12882930...lld:pubmed
pubmed-article:12882930pubmed:year2003lld:pubmed
pubmed-article:12882930pubmed:articleTitlePrevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.lld:pubmed
pubmed-article:12882930pubmed:affiliationDepartment of Biological Sciences, University of Essex, Central Campus, Wivenhoe Park, Colchester, Essex, UK.lld:pubmed
pubmed-article:12882930pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12882930pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12882930lld:pubmed